Trials / Unknown
UnknownNCT04320056
Closed-Loop Oxygen to Verify That Healthcare Workers Interventions Decrease During SARS-CoV-2 Pneumonia (COVID-19)
Automated Oxygen Titration - Monitoring and Weaning in Patients With Infectious Pneumonia Requiring Oxygen - Impact on the Number of Interventions for Healthcare Workers. An Innovative Device to Manage Patients With COVID-19 Pneumonia COVID Study (Closed-Loop Oxygen to Verify That Healthcare Workers Interventions Decreaseduring Pneumonia)
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 216 (estimated)
- Sponsor
- Laval University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
There is a high risk of transmission of COVID-19 to healthcare workers. In a recent cohort, 29% of the patients hospitalized were healthcare workers. Among the WHO's primary strategic objectives for the response to COVID-19, the first was to limit human-to-human transmission, including reducing secondary infections among close contacts and health care workers. Automated oxygen titration, weaning and monitoring (FreeO2 device) may be a solution to reduce the number of interventions of healthcare workers related to oxygen therapy, to reduce complications related to oxygen and to improve monitoring.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Standard administration of oxygen flow | The investigator recommended SpO2 target of 90-94%. The investigator will recommend that low/high SpO2 alarms be set at 88% and 96% if continuous oximetry is used. In this group the SpO2 was recorded any time with FreeO2 device - recording mode |
| DEVICE | Automated oxygen administration - FreeO2 | In this group, oxygen administration will be delivered with FreeO2 (automated oxygen titration) with SpO2 target set at 92% (to maintain oxygenation in the recommended SpO2 target: 90-94%) |
Timeline
- Start date
- 2020-04-20
- Primary completion
- 2021-04-30
- Completion
- 2021-10-31
- First posted
- 2020-03-24
- Last updated
- 2020-04-21
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT04320056. Inclusion in this directory is not an endorsement.